SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001082554-23-000022
Filing Date
2023-08-02
Accepted
2023-08-02 06:02:57
Documents
74
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q uthr-20230630.htm   iXBRL 10-Q 1776327
2 EX-10.2 uthrex10206302023.htm EX-10.2 14155
3 EX-31.1 uthrex31106302023.htm EX-31.1 11601
4 EX-31.2 uthrex31206302023.htm EX-31.2 11607
5 EX-32.1 uthrex32106302023.htm EX-32.1 6466
6 EX-32.2 uthrex32206302023.htm EX-32.2 6593
  Complete submission text file 0001082554-23-000022.txt   8247678

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20230630.xsd EX-101.SCH 45847
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20230630_cal.xml EX-101.CAL 69476
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20230630_def.xml EX-101.DEF 266834
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT uthr-20230630_lab.xml EX-101.LAB 710615
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20230630_pre.xml EX-101.PRE 453527
68 EXTRACTED XBRL INSTANCE DOCUMENT uthr-20230630_htm.xml XML 1320846
Mailing Address 1000 SPRING ST SILVER SPRING MD 20910
Business Address 1000 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 231133569
SIC: 2834 Pharmaceutical Preparations